PlexusDx coordinates with your cardiologist to ensure compatibility with your medical history
Market Segmentation Drug Class Insights (Revenue, USD Bn, 2021 - 2033) Exenatide Liraglutide Dulaglutide Lixisenatide Albiglutide Semaglutide Route of Administration Insights (Revenue, USD Bn, 2021 - 2033) Parenteral Oral Application Insights (Revenue, USD Bn, 2021 - 2033) Type 2 Diabetes Mellitus Obesity Liver Cirrhosis Non-alcoholic Steatohepatitis Others Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) Hospital Pharmacies Retail Pharmacies Online Pharmacies Regional Insights (Revenue, USD Bn, 2021 - 2033) North America U.S
To find the proportion of ESI enrollees with a prescription for GLP-1 drugs, outpatient pharmaceutical claims from 2012 to 2022 in the Merative MarketScan Commercial Database were used
Mar 16, 2026 Tirzepatide changed everything
June 6, 2024
Stay in touch with your care team